Ara
Toplam kayıt 6, listelenen: 1-6
Is the presence of left atrial diverticulum associated with recurrence in patients undergoing catheter ablation for atrial fibrillation?
(2019)
INTRODUCTION: Catheter ablation (CA) for atrial fibrillation (AF) has been a major cornerstone in the management of AF. Despite promising advances in CA techniques, long-term results reveal a high rate of recurrence after ...
Relationship between autonomic nervous system activity and recurrence after cryoballoon ablation in patients with paroxysmal atrial fibrillation
(University of Health Sciences, Kartal Koşuyolu High Specialization Training and Research Hospital, 2022)
Introduction: In this study, we aimed to investigate the relationship between autonomic dysfunction (AD) deter- mined according to the blood pressure (BP) and heart rate (HR) response in exercise treadmill test (ETT) prior ...
Changes in electrocardiographic p wave parameters after cryoballoon ablation and their association with atrial fibrillation recurrence
(Wiley-Blackwell, 2016)
Background: Changes in P wave parameters after circumferential pulmonary vein isolation (CPVI) have been previously identified. In this study, we aimed to determine the changes in P wave parameters surface electrocardiogram ...
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
(Lippincott Williams & Wilkins, 2016)
This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ...
Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence
(Via Medica, 2017)
Background: Myocardial injury induced by catheter ablation (CA) for atrial fibrillation (AF) leads to elevated biomarker levels. Aim: This prospective study examined levels of myocardial injury biomarkers (creatinine kinase ...
Hemopericardium and cardiac tamponade in a patient treated with dabigatran etexilate
(Korean Soc Cardiology, 2016)
Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports ...